chronic kidney disease
Modern CKD management
New therapeutic options for the treatment of chronic kidney disease (CKD) provide meaningful opportunities to slow progression and improve long-term outcomes if detected early. By Debbie Rigby, advanced practice pharmacist …
Empagliflozin PBS population expanded
Eligible patients more than doubled in line with largest trial on SGLT-2 inhibitors in CKD The PBS listing of Jardiance (empagliflozin 10mg) will be significantly expanded to include a broader …
Sick day management of medicines
Sick day management of medicines is a vital but often overlooked component of safe pharmacotherapy. Pharmacists are critically positioned to lead this initiative through medication reviews, point-of-care counselling, and interprofessional …
New pack size to ‘help address supply shortage’
PBAC recommends expanding empagliflozin treatment population in line with “pivotal” trial, changes to max quantities for pioglitazone and listing of new contraceptive choice in May meeting The PBAC has recommended …
Research roundup
Debbie Rigby takes a look at the latest in research news Mirtazapine for chronic insomnia in older adults: a randomised double-blind placebo-controlled trial-the MIRAGE study Mirtazapine promotes sleep by blocking serotonin and …
Dialysis patients sometimes on ‘up to 20 tablets in one day’
Pharmacy interventions are crucial to supporting people with kidney disease, says senior renal pharmacist Hospital pharmacists are helping to improve the management of anaemia and blood pressure in people with …